Search - tctmd.com

Displaying 401 - 420 of 2612

Sort: Relevancy | Date

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

Presentation TCT 2022

TCT 4: Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation

Presenter: Johny Nicolas

September 17, 2022

Presentation TCT 2022

TCT 3: Predictors of major bleeding complications in patients undergoing percutaneous coronary intervention: A contemporary system wide analysis

Presenter: Tia Bimal

September 17, 2022

Presentation TCT 2022

TCT 2: Two-Year Outcomes in High Bleeding Risk Patients with Bifurcations after Percutaneous Coronary Intervention and One Month Dual Antiplatelet Therapy

Presenter: Ajay Kirtane

September 17, 2022

Presentation TCT 2022

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

Presenter: Dennis Narcisse

September 17, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

Presentation TCT 2022

2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

Presenter: Craig Beavers

September 16, 2022

News Industry News

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

September 16, 2022

News Daily News

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

L.A. McKeown

September 09, 2022

News Daily News

Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI

Yael L. Maxwell

September 08, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

Todd Neale

September 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

Advertisement

FLASH: More Data to Support Mechanical Thrombectomy in PE

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

TCT 4: Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation

TCT 3: Predictors of major bleeding complications in patients undergoing percutaneous coronary intervention: A contemporary system wide analysis

TCT 2: Two-Year Outcomes in High Bleeding Risk Patients with Bifurcations after Percutaneous Coronary Intervention and One Month Dual Antiplatelet Therapy

TCT 1: Bleeding in Patients with Atrial Fibrillation and Acute Coronary Syndrome or PCI treated with Antithrombotic Therapy: Insights from the AUGUSTUS Trial

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI

CV Care Around Noncardiac Surgery: New ESC Guidelines

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

TCTMD’s Top 10 Most Popular Stories for August 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content